Vanguard Group Inc. Sells 29,696 Shares of Cabot Corporation $CBT

Vanguard Group Inc. trimmed its stake in Cabot Corporation (NYSE:CBT) by 0.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,928,895 shares of the specialty chemicals company’s stock after selling 29,696 shares during the quarter. Vanguard Group Inc. owned approximately 0.11% of Cabot worth $392,967,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of CBT. NewEdge Advisors LLC grew its stake in Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after purchasing an additional 947 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after acquiring an additional 108,645 shares during the period. Empowered Funds LLC boosted its stake in shares of Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after acquiring an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after acquiring an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on CBT shares. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. UBS Group lifted their target price on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Mizuho lifted their target price on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $85.00 target price on shares of Cabot in a research note on Wednesday, February 4th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Cabot has an average rating of “Hold” and a consensus target price of $75.00.

Cabot Stock Performance

NYSE:CBT opened at $82.28 on Thursday. The stock has a market cap of $4.30 billion, a P/E ratio of 15.55, a PEG ratio of 10.41 and a beta of 0.78. The stock has a 50 day simple moving average of $73.83 and a 200 day simple moving average of $70.35. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $85.27.

Cabot (NYSE:CBT) last released its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.31 million. Cabot had a return on equity of 21.28% and a net margin of 7.97%.The firm’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period last year, the firm posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts anticipate that Cabot Corporation will post 6.27 earnings per share for the current year.

Cabot Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Friday, May 29th. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is 31.52%.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.